ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
Clinical trials for ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered donor cells take on lymphoma in early trial
Disease control Recruiting nowThis early-phase study tests a new approach for patients with certain lymphomas (Hodgkin, NK/T-cell, and others) that have returned or not responded to treatment. The therapy uses immune cells from healthy donors that are specially trained in the lab to attack cancer cells carryi…
Matched conditions: ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill may keep rare lymphoma in check after chemo
Disease control Recruiting nowThis study tests whether the drug golidocitinib can help keep peripheral T-cell lymphoma (a rare blood cancer) from coming back after initial chemotherapy. About 136 adults who had a good response to first treatment but cannot or choose not to have a stem cell transplant will tak…
Matched conditions: ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC